All Stories

  1. Biosensor Technologies and Smart Dressings for Chronic Wound Monitoring: A Systematic Review
  2. Neoplastic Foot Ulcers: A Multicentre Retrospective Study
  3. Scalp Melanoma in a Young Patient With Systemic Sarcoidosis: Multidisciplinary Approach
  4. Ultra‐high frequency ultrasound predicts baricitinib response in alopecia areata: Towards personalized treatment
  5. Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
  6. Efficacy and safety of a medical device based on hyaluronic acid and amino acids for the topical treatment of hard-to-heal skin ulcers: a pilot clinical trial
  7. Upadacitinib dose adjustment in moderate‐to‐severe atopic dermatitis: insights from a multicenter real‐world study
  8. Assessing the burden of dermatological diseases on work life from a gender perspective
  9. Correlation Between Ultra‐High Frequency Ultrasound (UHFUS) and Histological Features of Typical Lesions in Hidradenitis Suppurativa
  10. Prurigo Nodularis at Ultra-High-Frequency Ultrasound
  11. Foliage Intense Filler, Affects Nasolabial Folds Wrinkles: Effectiveness and Safety by Prospective Comparative Study
  12. Recalcitrant Grover's disease treated with dupilumab: two long‐term cases and review of the literature
  13. Clinical impact of zinc oxide compression bandaging in chronic venous disease assessed with ultrasonography and trans-epidermal water loss – preliminary observations
  14. Incidence of therapy switch in patients with moderate to severe palmoplantar psoriasis treated with anti-IL 17 and anti-IL 23 monoclonal antibodies: a retrospective observational study
  15. Ultra-High Frequency Ultrasound (UHFUS) Features of Pyoderma Gangrenosum, Venous Leg Ulcers, and Acute Ulcerative Lesions
  16. High-Frequency and Ultra-High-Frequency Ultrasound in Dermatologic Diseases and Aesthetic Medicine
  17. Correlation between skin cancer and therapy with anti-IL monoclonal antibodies in patients affected by moderate-to-severe psoriasis: an observational monocentric study
  18. Tirbanibulin in actinic keratosis treatment: evaluation of effectiveness, safety and patients’ satisfaction in a comparison with cryotherapy
  19. High-Frequency and Ultra-High-Frequency Ultrasound in Dermatologic Diseases and Aesthetic Medicine
  20. Effectiveness of wide local excision and secondary intention healing in hidradenitis suppurativa: a single-centre study on quality of life and mental health outcomes
  21. Paradoxical Eczematous Eruptions in Patients with Psoriasis Treated with Biological Therapy
  22. Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study
  23. Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis
  24. Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
  25. Interleukin‐1 family cytokines and soluble receptors in hidradenitis suppurativa
  26. Evaluation of post-surgical complications of hidradenitis suppurativa lesions explored with presurgical ultra-high frequency ultrasound mapping
  27. Melanocytic nevi changes during pregnancy: What to do?
  28. Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study
  29. Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma Gangrenosum
  30. Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum
  31. Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study
  32. International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab
  33. Fluorescence-Based Evaluation of Bacterial Load in Perilesional Skin: A Comparison Between Short Stretch Bandage and Zinc Oxide Bandage
  34. The Role of Ultra-High-Frequency Ultrasound in Pyoderma Gangrenosum: New Insights in Pathophysiology and Diagnosis
  35. Ultra-High-Frequency Ultrasound as an Innovative Imaging Evaluation of Hyaluronic Acid Filler in Nasolabial Folds
  36. Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment
  37. Assessment and Monitoring of Nail Psoriasis with Ultra-High Frequency Ultrasound: Preliminary Results
  38. The diagnosis, management and prevention of intertrigo in adults: a review
  39. Pso-Reg: a web registry for psoriasis in real life
  40. Compression Therapy in Dermatology
  41. An Integrated Systemic and Local Wound Management in Recalcitrant Pyoderma Gangrenosum
  42. Pyoderma Gangrenosum in a Patient With Dubowitz Syndrome: a New Comorbidity?
  43. A Phase IIIb, Multicentre, Interventional, Randomised, Placebo‐Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G‐PLUS)
  44. Serum Amyloid A: A Potential New Marker of Severity in Hidradenitis Suppurativa
  45. Ultra‐High Frequency Ultrasound in Melanoma Management
  46. National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis
  47. Secukinumab demonstrated sustained retention, effectiveness and safety in a real‐world setting in patients with moderate‐to‐severe plaque psoriasis: long‐term results from an interim analysis of the SERENA study
  48. The Role of Autoflorescence Imaging Device in the Evaluation of Bacteria Burden Control
  49. The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma
  50. Parasites causing cutaneous wounds: Theory and practice from a dermatological point of view
  51. Impact of psychiatric comorbidities in psoriasis, hidradenitis suppurativa and atopic dermatitis: The importance of a psychodermatological approach
  52. Oral ivermectin: a feasible alternative to topical therapy of genital scabies
  53. Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis
  54. A real‐life experience as a proof of Guselkumab effectiveness and safety in patients with moderate to severe psoriasis
  55. Family history of psoriasis: a novel protective factor for therapy switch in patients treated with Secukinumab or Ixekizumab
  56. Palliative Management of a Recurrent Destructive Cutaneous Squamous Cell Carcinoma of the Scalp With Brain Exposure
  57. Blue light emission in the management of hard-to-heal wounds
  58. Local Management of Malignant and Unresectable Fungating Wounds: PEBO Assessment
  59. Effect of dupilumab on genital condylomata: a case report
  60. Echoentomography for Assessing Braconid Parasitization on Soft-Bodied Tephritid Hosts
  61. Umbilical giant condyloma acuminatum
  62. Unusual presentation of angiolymphoid hyperplasia with eosinophilia treated with intralesional and topic corticosteroid combination therapy
  63. Ultra-high-frequency ultrasound monitoring of melanomas arising in congenital melanocytic nevi: a case series
  64. Risk factors in pediatric melanoma: a retrospective study of 39 cases
  65. Ultrasound‐guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: A prospective study
  66. Seborrheic keratosis-like melanoma: a diagnostic challenge
  67. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review
  68. Evaluation of neutrophil extracellular trap deregulated formation in pyoderma gangrenosum
  69. The Association Between pH and Fluorescence as Noninvasive Diagnostic Tools in Chronic Wounds
  70. Ultra‐high‐frequency ultrasound and machine learning approaches for the differential diagnosis of melanocytic lesions
  71. Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack‐year on the response to therapy
  72. Ultra‐high‐frequency ultrasound monitoring of plaque psoriasis during ixekizumab treatment
  73. Wound Dehiscence After Achilles Tendon Trauma and Repair: Treatment With Ultraportable Negative Pressure Wound Therapy and Compression Therapy
  74. The potential role of propranolol in incontinentia pigmenti
  75. Improvement of severe facial seborrheic dermatitis following low-dose isotretinoin therapy
  76. Gynecomastia following isotretinoin treatment: a rare endocrine side effect
  77. 5% Lidocaine Hydrochloride Cream for Wound Pain Relief: A Multicentre Observational Study
  78. Surrounding skin management in venous leg ulcers: A systematic review
  79. Isotretinoin-triggered acne fulminans: a rare, disabling occurrence
  80. Dermatoscopic and ultra‐high frequency ultrasound evaluation in cutaneous postradiation angiosarcoma
  81. PG‐TIME : A practical approach to the clinical management of pyoderma gangrenosum
  82. <p>Using Skin Bioengineering to Highlight How Weight and Diabetes Mellitus Modify the Skin in the Lower Limbs of Super-Obese Patients</p>
  83. Triticum vulgare Extract Modulates Protein-Kinase B and Matrix Metalloproteinases 9 Protein Expression in BV-2 Cells: Bioactivity on Inflammatory Pathway Associated with Molecular Mechanism Wound Healing
  84. Atypical Ulcers: Diagnosis and Management
  85. A giant annular rash in a woodman: the many faces of erythema chronicum migrans
  86. Itch in Chronic Wounds: Pathophysiology, Impact, and Management
  87. Biomodulation induced by fluorescent light energy versus standard of care in venous leg ulcers: a retrospective study
  88. Intraoral Ultra‐High Frequency Ultrasound study of oral lichen planus: A pictorial review
  89. Tuscan consensus on the diagnosis and treatment of hidradenitis suppurativa
  90. Topical purified omental lipid formulations in the prevention of skin ulcers: a narrative review
  91. Potential role of serum amyloid A in hidradenitis suppurativa
  92. Breast surgeons dealing with Munchausen syndrome: A self‐induced necrotic phlegmon of the breast treated with surgery, negative pressure and epidermal fractional skin grafting
  93. Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel
  94. Tuscan consensus on the use of UVBnb phototherapy in the treatment of psoriasis
  95. Is it really just a small world?
  96. Sex‐related differences of clinical features in hidradenitis suppurativa: analysis of an Italian‐based cohort
  97. Necrotoxic spider bite: a successful noninvasive wound management
  98. Risankizumab for the treatment of moderate to severe psoriasis
  99. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial
  100. Enhancing daily practice through knowledge sharing
  101. Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group
  102. Cell salvage in acute and chronic wounds: a potential treatment strategy. Experimental data and early clinical results
  103. Acne fulminans associated with lymecycline intake: a case report
  104. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directe
  105. Elderly psoriatic patients under biological therapies: an Italian experience
  106. Catching the vulnologists around the globe
  107. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries
  108. Long-Term Outcome of Adalimumab in a Young Girl with Hidradenitis Suppurativa
  109. The Hidradenitis Suppurativa (HS) “Multidisciplinary Unit”: a rationale and practical proposal for an organised clinical approach
  110. Optimising collaboration in science and clinical practice
  111. Scanning the Immunopathogenesis of Psoriasis
  112. Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients
  113. Determination of salivary α-amylase and cortisol in psoriatic subjects undergoing the Trier Social Stress Test
  114. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis
  115. Sensors and Biosensors for C-Reactive Protein, Temperature and pH, and Their Applications for Monitoring Wound Healing: A Review
  116. EUREKA study – the evaluation of real-life use of a biophotonic system in chronic wound management: an interim analysis
  117. A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.
  118. Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus
  119. Biomarkers—an unmet need in wound care
  120. Evaluation of osteopontin expression in chronic wounds: a potential prognostic and therapeutic biomarker
  121. Biomarkers for psoriasis skin lesions
  122. The management of moderate-to-severe chronic plaque psoriasis
  123. Introducing the new WUWHS executive and editorial board
  124. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
  125. Temperature and pH sensors based on graphenic materials
  126. Association between HCV infection and cutaneous-mucosal lichen planus: an update
  127. TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand
  128. Retroauricular angiolymphoid hyperplasia with eosinophilia: sustained long-term remission following treatment with corticosteroids
  129. Tuscan consensus on the diagnosis, treatment and follow-up of moderate-to-severe psoriasis
  130. Primary cutaneous diffuse large B-cell lymphoma presenting as chronic non-healing ulcer
  131. Temperature- and pH-sensitive wearable materials for monitoring foot ulcers
  132. Optimizing acitretin use in patients with plaque psoriasis
  133. Contact dermatitis in patients with chronic leg ulcers: a common and neglected problem: a review 2000–2015
  134. No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents
  135. Epidermal skin grafting in vitiligo: a pilot study
  136. Use of advanced technologies across the wound care spectrum: prologue
  137. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
  138. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis
  139. The world of wounds comes together
  140. Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity
  141. Small molecules and antibodies for the treatment of psoriasis: a patent review (2010–2015)
  142. Recommendations for the management of biofilm: a consensus document
  143. A revolutionary therapeutic approach for psoriasis: bispecific biological agents
  144. Optimizing Technology Use for Chronic Lower-Extremity Wound Healing
  145. A D-optimal design to model the performances of dressings and devices for negative pressure wound therapy
  146. Difficult-to-heal wounds of mixed arterial/venous and venous etiology: a cost-effectiveness analysis of extracellular matrix
  147. What's new: Management of venous leg ulcers
  148. What's new: Management of venous leg ulcers
  149. Erratum: Erratum: Dynamic markers based on blood perfusion fluctuations for selecting skin melanocytic lesions for biopsy
  150. The use of a collagen matrix in hard-to-heal venous leg ulcers
  151. Skin Physiology of the Neonate and Infant: Clinical Implications
  152. Dynamic markers based on blood perfusion fluctuations for selecting skin melanocytic lesions for biopsy
  153. Hidradenitis Suppurativa and Wound Management
  154. Biologic drugs in wound management
  155. Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers – a randomized pilot study
  156. Fractional epidermal skin grafting
  157. The role of biomedical sensors in wound healing
  158. Atrophie Blanche
  159. Cryoglobulinemia
  160. SWAN-iCare : prise en charge des plaies de pied diabétique par pression négative et monitoring à distance de la cicatrisation
  161. 24thAnnual Meeting of the European Tissue Repair Society
  162. Quantitative Evaluation of Maceration in Venous Leg Ulcers by Transepidermal Water Loss (TEWL) Measurement
  163. Chronic wound management and research
  164. Physical Therapy in Wound Healing, Edema, and Urinary Incontinence
  165. Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach
  166. Introduction
  167. Cutaneous ulcers associated with hydroxyurea therapy
  168. Dear readers
  169. Cutaneous foetal injuries related to amniocentesis
  170. Improvement of Periulcer Skin Condition in Venous Leg Ulcer Patients
  171. SWAN-iCare: A smart wearable and autonomous negative pressure device for wound monitoring and therapy
  172. Use of diagnostics in wound management
  173. Efficacy of Adalimumab for the Treatment of Refractory Paediatric Acrodermatitis Continua of Hallopeau
  174. Measurements in Wound Healing
  175. A temperature sensor based on a MWCNT/SEBS nanocomposite
  176. Skin and Vascular Assessments
  177. Skin temperature monitoring by a wireless sensor
  178. Classification of Wounds at Risk and Their Antimicrobial Treatment with Polihexanide: A Practice-Oriented Expert Recommendation
  179. Evaluation of the Efficacy and Tolerability of a Solution Containing Propyl Betaine and Polihexanide for Wound Irrigation
  180. Dilemmas in measuring and using pressure ulcer prevalence and incidence: an international consensus
  181. Ibuprofen slow-release foam dressing reduces wound pain in painful exuding wounds: Preliminary findings from an international real-life study
  182. Efficacy and tolerance of a hydrocolloid dressing containing hyaluronic acid for the treatment of leg ulcers of venous or mixed origin
  183. Clinical significance of cutaneous proteoglycan (mucin) infiltration in patients with mitral valve prolapse
  184. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: Experimental and clinical evidence  ||FREE PAPER||
  185. Use of Nanotechnology-Designed Footsock in the Management of Preulcerative Conditions in the Diabetic Foot: Results of a Single, Blind Randomized Study
  186. Dressing‐related pain in patients with chronic wounds: an international patient perspective
  187. Hip fracture and pressure ulcers – the Pan-European Pressure Ulcer Study – intrinsic and extrinsic risk factors
  188. Hydroxyurea-Induced Leg Ulcers Treated With a Protease-Modulating Matrix
  189. Wound Assessment by 3-Dimensional Laser Scanning
  190. Improvement of Idiopathic Pyoderma Gangrenosum During Treatment With Anti-Tumor Necrosis Factor Alfa Monoclonal Antibody
  191. OASIS�wound matrix versus Hyaloskin�in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology
  192. Prevention and management of pressure ulcers
  193. Microcirculation - a Blarney Stone to Wound Healing
  194. The effect of amelogenins (Xelma™) on hard-to-heal venous leg ulcers
  195. Cutaneous Tissue Engineering and Lower Extremity Wounds (Part 2)
  196. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial
  197. Wound bed preparation and a brief history of TIME
  198. Semiquantitative Analysis of the Histopathological Features of the Neuropathic Foot Ulcer: Effects of pressure relief
  199. Angiogenesis and nerve regeneration in a model of human skin equivalent transplant
  200. Wound bed preparation: a systematic approach to wound management
  201. Sodium carboxyl-methyl-cellulose dressings in the management of deep ulcerations of diabetic foot
  202. Hardness of Plantar Skin in Diabetic Neuropathic Feet
  203. Use of a durometer to measure the degree of skin induration in lipodermatosclerosis
  204. The effect of topical nitroglycerin on transcutaneous oxygen